Abbreviations ADT androgen deprivation therapy; ALK anaplastic lymphoma kinase; ATO arsenic trioxide; CTLA 4 cytotoxic T lymphocyte protein 4; EGFR epidermal growth factor receptor; FLT3 FMS like tyrosine kinase 3; ICP immune checkpoint inhibitor; TKI tyrosine kinase inhibitor; mTOR mechanistic target of rapamycin; PI3K phosphoinositide 3 kinase; PD 1 programmed cell death protein 1; T1DM type 1 diabetes mellitus; T2DM type 2 diabetes mellitus
priligy cvs